PortViewPortView
DaVita logo

DaVita (DVA) Stock Analysis

NYSEHealthcareMedical - Care Facilities

$179.05+1.65%
1-year price historyRange $103.87 – $240.96
52-week range$179.05
$101.00$247.49

What DaVita does

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Key metrics

Market cap
$11.49B
P/E (TTM)
13.99
EPS (TTM)
$12.80
Beta
0.87
Dividend yield
0.00%
Revenue / share
$216.26
50-day avg
$210.13
200-day avg
$163.16
52-week high
$247.49
52-week low
$101.00
CEO
Javier J. Rodriguez

ETFs linked to DVA

Broad-market and Healthcare sector ETFs an investor holding DaVita is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DVA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DVA in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for DaVita?
DaVita trades under the ticker DVA on NYSE.
Which exchange is DVA listed on?
DVA is listed on NYSE.
What sector does DaVita operate in?
DaVita is classified in the Healthcare sector (Medical - Care Facilities industry).
How can PortView help analyze DVA in a portfolio?
PortView shows DVA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.